Aegerion CEO Beer, COO Fraser resign

Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) CEO and director Marc Beer and COO Craig Fraser resigned. Board member Sandford Smith will be interim CEO and will assume Fraser's responsibilities. The rare disease company does not plan to fill the COO position.

Smith, who joined Aegerion's board in 2012, was EVP and president of the international group at the Genzyme Corp. unit of Sanofi (Euronext:SAN; NYSE:SNY). ...